4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Anthem Biosciences Limited (ANTHEM) operates in the Biotechnology industry and is headquartered in Bengaluru, India with about 2,282 employees. Its market capitalization is roughly ₹522 billion. In the fiscal year ended 2026-03-31, ANTHEM reported ₹21.2B in revenue and ₹5.9B in net income.
Anthem Biosciences Limited operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally. It operates in two segments: Contract Manufacturing, Development & Discovery Services; and Speciality Ingredients.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹21.2B | ₹18.4B | ₹14.2B | ₹10.6B | — |
| Gross Profit | ₹13.1B | ₹11.0B | ₹8.2B | ₹7.2B | — |
| Operating Income (EBIT) | ₹7.1B | ₹5.9B | ₹4.2B | ₹3.7B | — |
| Net Income | ₹5.9B | ₹4.5B | ₹3.7B | ₹3.9B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Total Revenue | ₹4.2B | ₹6.1B | ₹4.2B | ₹5.5B | ₹5.4B |
| Gross Profit | ₹2.7B | ₹4.0B | ₹2.8B | ₹3.3B | ₹3.1B |
| Operating Income (EBIT) | ₹1.2B | ₹2.3B | ₹1.2B | ₹1.8B | ₹1.7B |
| Net Income | ₹1.2B | ₹1.9B | ₹928M | ₹1.7B | ₹1.4B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | — | — | ₹0M |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹34.3B | ₹28.1B | ₹24.0B | ₹20.1B | — |
| Total Liabilities | ₹3.9B | ₹4.0B | ₹4.7B | ₹2.7B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ANTHEM viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms